Insider Transactions in Q4 2025 at Entrada Therapeutics, Inc. (TRDA)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 21
2025
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,910
-7.49%
|
$80,190
$9.98 P/Share
|
|
Nov 20
2025
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
28,867
+0.3%
|
$259,803
$9.07 P/Share
|
|
Nov 14
2025
|
5 Am Ventures V, L.P. |
SELL
Open market or private sale
|
Direct |
200,000
-6.32%
|
$1,600,000
$8.8 P/Share
|
|
Nov 14
2025
|
Kush Parmar |
SELL
Open market or private sale
|
Indirect |
200,000
-6.32%
|
$1,600,000
$8.8 P/Share
|
|
Nov 12
2025
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
100,736
+1.03%
|
$705,152
$7.84 P/Share
|
|
Nov 11
2025
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
46,434
+0.49%
|
$325,038
$7.47 P/Share
|
|
Nov 10
2025
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
30,874
+0.33%
|
$216,118
$7.22 P/Share
|